Prophylactic Intra-aortic Balloon Counterpulsation—Still Searching for Answers

Townsley, Matthew M.

doi:10.1053/j.jvca.2018.01.051

Cited by 5 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The discordant nature of evidence persists in studies examining the effects of pre-operative IABP insertion, with a lack of consensus regarding its impact on morbidity and mortality [5][6][7]. A meta-analysis encompassing 11 studies, comparing outcomes following prophylactic IABP implementation before percutaneous coronary intervention, reported no signi cant clinical improvements [8].…”

Section: Introductionmentioning

confidence: 99%

Pre-operative intra-aortic balloon pump insertion in coronary artery bypass grafting patients reduces in-hospital morbidity

Sazzad,

Luo,

Chang

et al. 2024

Preprint

View full text Add to dashboard Cite

Background: The aim of this study was to determine if pre-operative intra-aortic balloon pump (IABP) insertion improves the surgical outcomes of coronary artery bypass grafting (CABG). Methods: Patients with EuroSCORE II > 1.2% who underwent CABG from 2009 to 2016 were included in the study. Patients who utilized intra-operative or post-operative IABP were excluded. The analysis included a total of 2907 patients, with 377 patients undergoing pre-operative IABP insertion and 1198 patients receiving no IABP support. Following propensity score matching, 250 patients from each group were eligible for further analysis. Results: 30-day mortality events occurred in 9 (3.6%) non-IABP users and in 12 (4.8%) IABP users (OR: 1.33 95%CI: 0.52–3.58). Kaplan-Meier survival curve analysis showed no significant differences between the two groups in mortality up to one year after the operation (p = 0.72). On multivariate analysis, IABP usage among the PSM patients was associated with lower 30-day mortality (OR: 0.28, 95%CI: 0.07–0.92, P-value = 0.043), 90-day mortality (OR: 0.26, 95%CI: 0.08–0.78, P-value = 0.022) and reduced risk of developing severe respiratory disorders (OR: 0.10, 95%CI:0.01–0.50, P-value = 0.011). Conclusion: Pre-operative IABP use in high-risk patients reduces 30- and 90-day mortality rates, along with a notable decrease in rates of severe respiratory disorders.

show abstract

Section: Introductionmentioning

confidence: 99%

Pre-operative intra-aortic balloon pump insertion in coronary artery bypass grafting patients reduces in-hospital morbidity

Sazzad,

Luo,

Chang

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Is preoperative IABP insertion significantly reducing postoperative complication in augmented high-risk coronary artery bypass grafting patients?

Sazzad,

Luo,

Chang

et al. 2024

J Cardiothorac Surg

View full text Add to dashboard Cite

Background The aim of this study was to determine whether pre-operative intra-aortic balloon pump (IABP) insertion improves surgical outcomes in high-risk coronary artery bypass grafting (CABG) patients. Methods Patients with a EuroSCORE II greater than 1.2% who underwent CABG from 2009 to 2016 were included in the study, while those who utilized intra-operative or post-operative IABP were excluded. The analysis included a total of 2907 patients, with 377 patients undergoing preoperative IABP insertion (EuroSCORE II > 5.018%) and 1198 patients in the non-IABP group before matching; after propensity score matching (PSM), both groups consisted of a matched cohort of 250 patients. Results 30-day mortality events occurred in 9 (3.6%) non-IABP group and in 12 (4.8%) IABP patients (OR: 1.33 95%CI: 0.52–3.58). Kaplan-Meier survival curve analysis showed no significant differences between the two groups in mortality up to one year after the operation (p = 0.72). On multivariate analysis, IABP usage among the PSM patients was associated with lower 30-day mortality (OR: 0.28, 95%CI: 0.07–0.92, P-value = 0.043), 90-day mortality (OR: 0.26, 95%CI: 0.08–0.78, P-value = 0.022) and reduced risk of developing severe respiratory disorders (OR: 0.10, 95%CI:0.01–0.50, P-value = 0.011). Conclusion Pre-operative IABP use in high-risk patients reduces 30- and 90-day mortality rates, along with a notable decrease in rates of severe respiratory disorders.

show abstract

“…The primary findings demonstrated that preoperative utilization of IABP in cardiac surgery was safe throughout the trial period, even for high-risk patients. [37] IABP which was first used in clinical care by Dr. Adrian Kantrowitz in the 1960s, has remained a crucial therapy in the treatment of CAD patients [38].…”

mentioning

confidence: 99%

Analysis of Intra-Aortic Balloon Performance in Open-Heart Surgery

Wajeeh,

Hamandi,

Alobaidi

et al. 2023

NJES

View full text Add to dashboard Cite

A failing heart can be supported in several ways, including cardiopulmonary bypass pumps (CPB), extracorporeal membrane oxygenators (ECMOs), and other types of auxiliary heart pumps. The intra-aortic-balloon-pump (IABP) is one technique of internal counter-pulsation that supports maintaining the circulatory system It continues to be used as a vascular support device to critically unwell cardiac patients. Many recent studies have focused on the problems of the (IABP) in open-heart surgery, while other researchers concentrated on the positioning and size of the balloon, some of them studied the timing of the balloon's inflation and deflation. this paper has reviewed a brief Introduction, the basic principles of the balloon, how to trigger the balloon pump as well as the use of IABP in Coronary Artery Bypass Graft (CABG), balloon mistiming of inflation and deflation, balloon timing usage within open-heart surgery and finally a balloon position and sizing.

show abstract

Prophylactic Intra-aortic Balloon Counterpulsation—Still Searching for Answers

Cited by 5 publications

References 9 publications

Pre-operative intra-aortic balloon pump insertion in coronary artery bypass grafting patients reduces in-hospital morbidity

Pre-operative intra-aortic balloon pump insertion in coronary artery bypass grafting patients reduces in-hospital morbidity

Is preoperative IABP insertion significantly reducing postoperative complication in augmented high-risk coronary artery bypass grafting patients?

Analysis of Intra-Aortic Balloon Performance in Open-Heart Surgery

Contact Info

Product

Resources

About